Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Early chest CT scans sharpen pneumonia prediction in stroke patients

NCT ID NCT07321275

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 1499 people who had an acute ischemic stroke and got a chest CT within 24 hours. Researchers wanted to see if combining CT findings with clinical signs and inflammation markers could better predict who would develop pneumonia within a week. They built and tested a new prediction model that may help doctors identify high-risk patients earlier.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,499 people

The number who actually took part.

Started

Jan 2026

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults (≥18 years) with neuroimaging-confirmed acute ischemic stroke admitted to participating tertiary stroke centers in China. Eligibility requires chest CT performed within 24 h of stroke onset . Patients will be retrospectively identified from electronic medical records and stroke registries, and stroke-associated pneumonia will be assessed within 7 days after stroke onset using prespecified criteria. Only the first eligible admission per individual will be included.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: 1. patients aged ≥18 years; 2. Admitted to a participating stroke centre with neuroimaging-confirmed acute ischaemic stroke ; 3. Had chest CT performed within 24 hours of stroke onset. Exclusion criteria: 1. Pneumonia; 2. Chest CT images unavailable or incomplete for assessment; 3. Insufficient clinical documentation to ascertain stroke-associated pneumonia occurrence within 7 days after stroke onset

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute ischaemic stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Central Hospital of Xiangtan

    Xiangtan, Hunan, 411100, China

  • First Affiliated Hospital of Soochow University

    Suzhou, Jiangsu, China

  • Ningjin County People's Hospital

    Fenghuang, Hebei, 055550, China

  • Rongcheng County People's Hospital

    Baoding, Hebei, China

  • Shihezi People's Hospital,

    Shihezi, Xinjiang, 836800, China

  • Suzhou Municipal Hospital of Anhui Province

    Suzhou, Anhui, 234000, China

  • The Second Hospital of Hebei Medical University,

    Shijiazhuang, Hebei, 050061, China

  • Xuanwu Hospita

    Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.